With 0.96 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.41 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $1.58 whereas the lowest price it dropped to was $1.38. The 52-week range on MYNZ shows that it touched its highest point at $10.56 and its lowest point at $1.21 during that stretch. It currently has a 1-year price target of $14.00. Beta for the stock currently stands at 0.24.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MYNZ was up-trending over the past week, with a rise of 9.16%, but this was up by 1.42% over a month. Three-month performance dropped to -20.56% while six-month performance fell -41.39%. The stock lost -66.90% in the past year, while it has lost -87.08% so far this year. EPS is expected to grow by 59.64% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -52.02%.
Float and Shares Shorts:
At present, 5.41 million MYNZ shares are outstanding with a float of 5.34 million shares on hand for trading. On 2025-10-31, short shares totaled 36944.0, which was 68.0 higher than short shares on 1759190400. In addition to Mr. Guido Baechler as the firm’s CEO & Executive Director, Dr. Christopher Von Toerne P.M.P., Ph.D. serves as its Chief Operating Officer.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With MYNZ analysts setting a high price target of 14.0 and a low target of 14.0, the average target price over the next 12 months is 14.0. Based on these targets, MYNZ could surge 879.02% to reach the target high and rise by 879.02% to reach the target low. Reaching the average price target will result in a growth of 879.02% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$10.84 being high and -$10.84 being low. For MYNZ, this leads to a yearly average estimate of -$10.84.
